
The driving objective behind SOMARTEX (Self Operating MARine Trapping EXtractor) is to ensure the protection of marine invertebrate biodiversity while meeting the need to provide the drug pipeline with marine natural scaffolds and bioactive compounds. The main principle is the trapping of invertebrate holobionts molecules in their natural habitat at any location and depth, without harvesting the organism. SOMARTEX is patented and was financed independently by CNRS. The technology will be validated and exploited within the TASCMAR project.
Patent
-
Patent
Category 1Somartex, Self Operating MARine Trapping EXtractor. CNRS, INPI 1850669, 2018
Jamal OUAZZANI, Géraldine LE GOFF
Partner
-
Tascmar
The construction of the equipment is fully financed by TASCMAR European Union’s Horizon 2020 research and innovation program under grant agreement No 634674.